2006

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced preliminary, unaudited first quarter revenues of approximately $894 million, reflecting a decline of approximately 6 percent...

Company Expects European Launch of XIENCE V in Third Quarter 2006 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that a small percentage (approximately 1 percent) of the...

Panel Chaired by Dr. Myerburg, an Internationally Recognized Leader in Electrophysiology; In-Depth Analyses and Eight Major Recommendations Provided to the Corporation Indianapolis, Ind. - Guidant...

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in...

Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that it will begin construction on expanded facilities in...

Large-Scale Trial Evaluating Safety and Efficacy of Next-Generation XIENCE(tm) V Coronary Stent System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...

Results from 2,500 Patients Suggest Therapy Can Be Performed Safely by Broad Group of Physicians Indianapolis, Ind. and Atlanta - Guidant Corporation (NYSE: GDT) today announced updated results of...

Guidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac Defibrillators Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily...

R. Frederick McCoy, Jr., Elects Early Retirement from Guidant Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Fred McCoy, president, Guidant Cardiac Rhythm Management,...

RX HERCULINK ELITE Biliary Stent System Provides Superb Deliverability with Increased Radial Strength, Visibility and Stent Flexibility Indianapolis, Ind. and Santa Clara, Calif. - Guidant...